Navigation Links
Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo
Date:10/19/2013

ST. LOUIS (PRWEB) October 19, 2013

The GranuFlo recall lawyers at Baron and Budd are reviewing GranuFlo claims relating to the March 2012 GranuFlo and NaturaLyte recall. Dialysis concentrates used during dialysis treatments to help clean the blood, both GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care, the world's largest provider of dialysis products. Both dialysis concentrates were recalled by the Food and Drug Administration (FDA) as a Class I recall, the highest form of drug recall in the United States used only when a medical product can cause serious health conditions or even death. (http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm)

Dialysis patients or their loved ones may be eligible to file a GranuFlo lawsuit with Baron and Budd's GranuFlo recall lawyers if they suffered from a heart attack during or following a dialysis treatment. This dialysis treatment may have involved the use of GranuFlo or NaturaLyte and therefore could be the cause of the patient's injury.

At this time, Baron and Budd is continuing to review GranuFlo lawsuit claims, providing individuals who may be eligible to file a GranuFlo lawsuit claim with a free legal consultation. All consultations are confidential.

The risk of heart attack associated with the use of GranuFlo and NaturaLyte involves the increased bicarbonate associated with these particular dialysis concentrates. Both GranuFlo and NaturaLyte are more likely to cause a higher level of bicarbonate in the blood compared to other dialysis concentrates in their class. As doctors were uninformed of the increased bicarbonate associated with GranuFlo and NaturaLyte, patients were in turn put at risk for heart attacks allegedly caused by an overdose of bicarbonate. (http://www.prweb.com/releases/2013/5/prweb10700127.htm)

"The FDA does not take Class I recalls lightly. These recalls occur only when there is a reasonable probability that the product could cause serious health condition or even death," says Russell Budd of Baron and Budd. “While the Class I recall is an important step in ensuring dialysis patient safety, work needs to be done to help patients who have already been injured. Our GranuFlo lawyers are taking the necessary steps to help these injured patients by providing confidential and free consultations to patients who have suffered heart attacks following dialysis treatment."

To learn more about Baron and Budd's work on the GranuFlo lawsuit please visit the firm's website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/granuflo-lawyer/

To speak with a GranuFlo lawyer as part of Baron and Budd's free and confidential GranuFlo recall consultations, please call 1.866.472.9108.

About Baron & Budd, P.C.

With a history of over 35 years “Protecting What’s Right” for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11248646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
4. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
5. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
6. Baron and Budd is Encouraged by the First Federal Transvaginal Mesh Lawsuit Verdict
7. Baron and Budd Announces Second Transvaginal Mesh Lawsuit Settlement for Bard
8. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
9. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
10. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
11. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , ... January 21, 2017 , ... ... its new medical office in Petaluma, located at 167 Lynch Creek Way. The ... to SRO sports medicine and rehabilitation services and on-site x-ray services. ...
(Date:1/20/2017)... ... , ... A new partnership between Goodwill® and Roadie, Inc. aims to make ... clothes to couches to dressers and bicycles. Roadie — the national on-the-way delivery network ... donation center through February 28th. , “January is an exciting time when resolutions ...
(Date:1/20/2017)... ... , ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality ... January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures ... its products to all clients at reasonable prices. At the ECRM trade show, it ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... , ... “The Angel”: a heartwarming and earnest tale of faith and ... children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional ... writer. , When asked of her new book, Marjorie says, “‘The Angel’ was written ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
(Date:1/19/2017)... -- Pfizer joins Astex, AstraZeneca, GlaxoSmithKline, ...   Major research investment to work ...   The Milner Therapeutics Institute today announces ... partner to the Milner Therapeutics Consortium. Pfizer has agreed ... of materials between industry and academia and allocation of ...
Breaking Medicine Technology: